308 related articles for article (PubMed ID: 31203497)
21. Thyroglobulin Changes are Highly Dependent on TSH in Low-risk DTC Patients not Treated with Radioiodine.
Matrone A; Faranda A; Latrofa F; Gambale C; Stefani Donati D; Molinaro E; Agate L; Viola D; Piaggi P; Torregrossa L; Basolo F; Elisei R
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32453405
[TBL] [Abstract][Full Text] [Related]
22. Ten-year estimated risk of bone fracture in women with differentiated thyroid cancer under TSH-suppressive levothyroxine therapy.
Vera L; Gay S; Campomenosi C; Paolino S; Pera G; Monti E; Mortara L; Seriolo B; Giusti M
Endokrynol Pol; 2016; 67(4):350-8. PubMed ID: 27387240
[TBL] [Abstract][Full Text] [Related]
23. Seasonal variations in TSH serum levels in athyreotic patients under L-thyroxine replacement monotherapy.
Gullo D; Latina A; Frasca F; Squatrito S; Belfiore A; Vigneri R
Clin Endocrinol (Oxf); 2017 Aug; 87(2):207-215. PubMed ID: 28398655
[TBL] [Abstract][Full Text] [Related]
24. Frequency of Thyroid Hormone Replacement After Lobectomy for Differentiated Thyroid Cancer.
Schumm MA; Lechner MG; Shu ML; Ochoa JE; Kim J; Tseng CH; Leung AM; Yeh MW
Endocr Pract; 2021 Jul; 27(7):691-697. PubMed ID: 33642257
[TBL] [Abstract][Full Text] [Related]
25. Assesment of attainment of recommended TSH levels and levothyroxine compliance in differentiated thyroid cancer patients.
Yavuz DG; Yazan CD; Hekimsoy Z; Aydin K; Gokkaya N; Ersoy C; Akalın A; Topaloglu O; Aydogan BI; Dilekci ENA; Alphan Uc Z; Cansu GB; Ozsari L; Iyidir OT; Olgun ME; Keskin L; Mert M; Can B; Gungor K; Galip T; Cantürk Z; Elbuken G; Pekkolay Z; Kutbay NO; Yorulmaz G; Kalkan AT; Unsal YA; Yay A; Karagun B; Bozkur E
Clin Endocrinol (Oxf); 2022 Dec; 97(6):833-840. PubMed ID: 35639050
[TBL] [Abstract][Full Text] [Related]
26. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
[TBL] [Abstract][Full Text] [Related]
27. Biochemical Effects of Levothyroxine Withdrawal in Patients with Differentiated Thyroid Cancer.
Papadakis G; Kalaitzidou S; Triantafillou E; Drosou A; Kakava K; Dogkas N; Pappa T; Kaltzidou V; Tertipi A; Villiotou V; Pappas A
Anticancer Res; 2015 Dec; 35(12):6933-40. PubMed ID: 26637919
[TBL] [Abstract][Full Text] [Related]
28. Symptomatic Relief is Related to Serum Free Triiodothyronine Concentrations during Follow-up in Levothyroxine-Treated Patients with Differentiated Thyroid Cancer.
Larisch R; Midgley JEM; Dietrich JW; Hoermann R
Exp Clin Endocrinol Diabetes; 2018 Sep; 126(9):546-552. PubMed ID: 29396968
[TBL] [Abstract][Full Text] [Related]
29. Analysis of dose-TSH response effect of levothyroxine soft-gel formulation.
Trimboli P; Piticchio T; Dadda Z; Stramazzo I; Gamarra E; Ruinelli L; Virili C
Front Endocrinol (Lausanne); 2024; 15():1340204. PubMed ID: 38449850
[TBL] [Abstract][Full Text] [Related]
30. Measurement of serum TSH and thyroid hormones in the management of treatment of thyroid carcinoma with radioiodine.
Edmonds CJ; Hayes S; Kermode JC; Thompson BD
Br J Radiol; 1977 Nov; 50(599):799-807. PubMed ID: 588901
[TBL] [Abstract][Full Text] [Related]
31. Comparison of pathophysiology in subclinical hyperthyroidism with different etiologies.
Deguchi-Horiuchi H; Ito M; Takahashi S; Kousaka K; Hisakado M; Fukata S; Kudo T; Nishihara E; Nishikawa M; Miyauchi A; Akamizu T
Endocr J; 2024 Apr; 71(4):373-381. PubMed ID: 38296546
[TBL] [Abstract][Full Text] [Related]
32. Liquid liothyronine to obtain target TSH in differentiated thyroid cancer patients.
Trimboli P; Centanni M; Virili C
Endocr J; 2016 Jun; 63(6):563-7. PubMed ID: 27000530
[TBL] [Abstract][Full Text] [Related]
33. Preparation for radioactive iodine administration in differentiated thyroid cancer patients.
Liel Y
Clin Endocrinol (Oxf); 2002 Oct; 57(4):523-7. PubMed ID: 12354135
[TBL] [Abstract][Full Text] [Related]
34. Degree of thyrotropin suppression in differentiated thyroid cancer without recurrence or metastases.
Kamel N; Güllü S; Dağci Ilgin S; Corapçioğlu D; Tonyukuk Cesur V; Uysal AR; Başkal N; Erdoğan G
Thyroid; 1999 Dec; 9(12):1245-8. PubMed ID: 10646665
[TBL] [Abstract][Full Text] [Related]
35. Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy.
Verburg FA; Smit JW; Grelle I; Visser TJ; Peeters RP; Reiners C
Clin Endocrinol (Oxf); 2012 Apr; 76(4):577-81. PubMed ID: 22017394
[TBL] [Abstract][Full Text] [Related]
36. Factors influencing TSH suppression efficacy in postoperative papillary thyroid carcinoma patients: a retrospective cohort study.
Zhang Q; Zhong ZZ; Wu T; He YQ
BMC Surg; 2024 May; 24(1):133. PubMed ID: 38702652
[TBL] [Abstract][Full Text] [Related]
37. Higher preablative serum thyroid-stimulating hormone level predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma.
Lawal IO; Nyakale NE; Harry LM; Lengana T; Mokgoro NP; Vorster M; Sathekge MM
Nucl Med Commun; 2017 Mar; 38(3):222-227. PubMed ID: 28002173
[TBL] [Abstract][Full Text] [Related]
38. Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer.
Santoro AB; Vargens DD; Barros Filho Mde C; Bulzico DA; Kowalski LP; Meirelles RM; Paula DP; Neves RR; Pessoa CN; Struchine CJ; Suarez-Kurtz G
Br J Clin Pharmacol; 2014 Nov; 78(5):1067-75. PubMed ID: 24910925
[TBL] [Abstract][Full Text] [Related]
39. The different requirement of L-T4 therapy in congenital athyreosis compared with adult-acquired hypothyroidism suggests a persisting thyroid hormone resistance at the hypothalamic-pituitary level.
Bagattini B; Cosmo CD; Montanelli L; Piaggi P; Ciampi M; Agretti P; Marco GD; Vitti P; Tonacchera M
Eur J Endocrinol; 2014 Nov; 171(5):615-21. PubMed ID: 25305309
[TBL] [Abstract][Full Text] [Related]
40. The Influences of TSH Stimulation Level, Stimulated Tg Level and Tg/TSH Ratio on the Therapeutic Effect of
Zheng W; Rui Z; Wang X; Li N; Tan J; Liu W
Front Endocrinol (Lausanne); 2021; 12():601960. PubMed ID: 34177793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]